TVTX FY 2016 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$134M+33.7% YoY

Gross Profit

$129M96.6% margin

Operating Income

-$58M-43.6% margin

Net Income

-$48M-35.9% margin

EPS (Diluted)

$-1.25

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$14M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$525M

Total Liabilities

$218M

Stockholders' Equity

$308M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$134M	$100M	+33.7%
Gross Profit	$129M	$98M	+32.1%
Operating Income	-$58M	-$51M	-14.7%
Net Income	-$48M	$117M	-140.9%